Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Bowlin

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Rheumatology|April 17, 2003
Silicone gel breast implantsSteven J Bowlin
Mayo Clinic Proceedings|April 7, 2004
Thiazolidinedione-associated congestive heart failure and pulmonary edemaSteven J Bowlin, Carol E Koro
Neuropsychiatric Disease and Treatment|December 1, 2011
A large pharmacy claims-based descriptive analysis of patients with migraine and associated pharmacologic treatment patternsDavid J Muzina, William Chen, Steven J Bowlin
Pharmacoepidemiology and Drug Safety|January 18, 2005
Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indicationCarol E Koro, Steven J Bowlin, Sheila R Weiss
Ophthalmic Research|March 27, 2002
Antisilicone antibodies in patients with silicone implants for retinal detachment surgeryPaal C Klykken, Susan J Hoshaw, Steven J Bowlin
Diabetes Care|December 25, 2003
Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary reportCarol E Koro, Steven J Bowlin, Nancy Bourgeois, et al.
Diabetes Care|July 29, 2006
Ethnic disparities and trends in glycemic control among adults with type 2 diabetes in the U.S. from 1988 to 2002Tao Fan, Carol E Koro, Donald O Fedder, et al.
The American Journal of Cardiology|March 29, 2011
Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizationsDonald G Pittman, William Chen, Steven J Bowlin, et al.
Mayo Clinic Proceedings|February 5, 2013
Twelve-month frequency of drug-metabolizing enzyme and transporter-based drug-drug interaction potential in patients receiving oral enzyme-targeted kinase inhibitor antineoplastic agentsSteven J Bowlin, Fang Xia, Wenyi Wang, et al.
Clinical Therapeutics|May 9, 2006
The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-upGregory A Nichols, Carol E Koro, Wiley Chan, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Rheumatology|April 17, 2003
Silicone gel breast implantsSteven J Bowlin
Mayo Clinic Proceedings|April 7, 2004
Thiazolidinedione-associated congestive heart failure and pulmonary edemaSteven J Bowlin, Carol E Koro
Neuropsychiatric Disease and Treatment|December 1, 2011
A large pharmacy claims-based descriptive analysis of patients with migraine and associated pharmacologic treatment patternsDavid J Muzina, William Chen, Steven J Bowlin
Pharmacoepidemiology and Drug Safety|January 18, 2005
Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indicationCarol E Koro, Steven J Bowlin, Sheila R Weiss
Ophthalmic Research|March 27, 2002
Antisilicone antibodies in patients with silicone implants for retinal detachment surgeryPaal C Klykken, Susan J Hoshaw, Steven J Bowlin
Diabetes Care|December 25, 2003
Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary reportCarol E Koro, Steven J Bowlin, Nancy Bourgeois, et al.
Diabetes Care|July 29, 2006
Ethnic disparities and trends in glycemic control among adults with type 2 diabetes in the U.S. from 1988 to 2002Tao Fan, Carol E Koro, Donald O Fedder, et al.
The American Journal of Cardiology|March 29, 2011
Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizationsDonald G Pittman, William Chen, Steven J Bowlin, et al.
Mayo Clinic Proceedings|February 5, 2013
Twelve-month frequency of drug-metabolizing enzyme and transporter-based drug-drug interaction potential in patients receiving oral enzyme-targeted kinase inhibitor antineoplastic agentsSteven J Bowlin, Fang Xia, Wenyi Wang, et al.
Clinical Therapeutics|May 9, 2006
The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-upGregory A Nichols, Carol E Koro, Wiley Chan, et al.
Pageof 2